Cargando…

Neuroprotection in Glaucoma

Detalles Bibliográficos
Autor principal:	Nilforushan, Naveed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ophthalmic Research Center 2012
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381115/ https://www.ncbi.nlm.nih.gov/pubmed/22737394

Ejemplares similares

Surgical management of glaucoma in Fuchs uveitis syndrome: Trabeculectomy or Ahmed glaucoma valve
por: Nilforushan, Naveed, et al.
Publicado: (2018)

Wound Dehiscence and Device Migration after Subconjunctival Bevacizumab Injection with Ahmed Glaucoma Valve Implantation
por: Miraftabi, Arezoo, et al.
Publicado: (2016)

Evaluation of success after second Ahmed glaucoma valve implantation
por: Nilforushan, Naveed, et al.
Publicado: (2016)

Glaucoma in a Patient with Nanophthalmos
por: Nouri-Mahdavi, Kouros, et al.
Publicado: (2011)

Trans-Scleral Cyclophotocoagulation in Refractory Pigment Dispersion-Like Glaucoma Secondary to Ciliary Body Melanoma
por: Banifatemi, Mohammad, et al.
Publicado: (2022)

How Wld(S) neuroprotects
por: Williams, Ruth
Publicado: (2009)

Peripapillary and Macular Choroidal Thickness in Glaucoma
por: Hosseini, Hamid, et al.
Publicado: (2014)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Postoperative Blepharoptosis after Trabeculectomy versus Ahmed Glaucoma Valve Implantation
por: Nilforushan, Naveed, et al.
Publicado: (2022)

Effect of Yellow-Tinted Intraocular Lens on Standard Automated Perimetry and Short Wavelength Automated Perimetry in Patients with Glaucoma
por: Nilforushan, Naveed, et al.
Publicado: (2014)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

Anti-VEGF Agents and Glaucoma Filtering Surgery
por: Daneshvar, Ramin
Publicado: (2013)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015)

Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)

Novel Gene Mutations Causing Primary Congenital Glaucoma
por: Feizi, Sepehr
Publicado: (2010)

Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma
por: Daneshvar, Ramin, et al.
Publicado: (2014)

Neuroprotective and neurorestorative potential of xenon
por: Lavaur, J, et al.
Publicado: (2016)

The Impact of the COVID-19 Pandemic on Ophthalmology Residency Training
por: Nilforushan, Naveed, et al.
Publicado: (2021)

Current perspective of neuroprotection and glaucoma
por: Tian, Kailin, et al.
Publicado: (2015)

Neuroprotective agents in the management of glaucoma
por: Nucci, C., et al.
Publicado: (2018)

Contribution of the latent transforming growth factor-beta binding protein 2 gene to etiology of primary open angle glaucoma and pseudoexfoliation syndrome
por: Jelodari-Mamaghani, Sahar, et al.
Publicado: (2013)

Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma
por: Chou, Tsung-Han, et al.
Publicado: (2018)

New perspectives of immunomodulation and neuroprotection in glaucoma
por: Skopiński, Piotr, et al.
Publicado: (2021)

The promise of neuroprotection by dietary restriction in glaucoma
por: Russo, Rossella, et al.
Publicado: (2021)

Niacinamide and Neuroprotection: The Glaucoma Holy Grail
por: Bhartiya, Shibal
Publicado: (2022)

A Coming of Age for Glaucoma Neuroprotection
por: Johnson, Thomas V.
Publicado: (2023)

Cefixime-induced angle closure and transient myopic shift in a healthy individual; A case report
por: Mirshahi, Reza, et al.
Publicado: (2020)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

Neuroprotection in Glaucoma: Old and New Promising Treatments
por: Rusciano, Dario, et al.
Publicado: (2017)

Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
por: Tribble, James R., et al.
Publicado: (2021)

Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance
por: Kuo, Che-Yuan, et al.
Publicado: (2022)

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models
por: Youale, Jenny, et al.
Publicado: (2022)

Comparison of the long-term outcomes of resident versus attending performed trabeculectomy
por: Nilforushan, Naveed, et al.
Publicado: (2017)

Closed Gateways — Can Neuroprotectants Shield the Retina in Glaucoma?
por: Velpandian, Thirumurthy
Publicado: (2012)

Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma☆
por: Fang, Jiahua, et al.
Publicado: (2012)

Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
por: Can, Nagehan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m0aurp9cj0j9todl5skid50iqp